Search

Search Constraints

You searched for: Author/Creator Margolin, Kim A.

Search Results

1. A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG‐ACRIN Cancer Research Group (E2607). Issue 14 (23rd March 2017)

3. An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0. Issue 1 (30th May 2018)

4. Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials. Issue 1 (3rd October 2018)

5. Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma. (November 2017)

6. Melanoma central nervous system metastases: current approaches, challenges, and opportunities. (22nd October 2016)

7. NCI 8628: A randomized phase 2 study of ziv‐aflibercept and high‐dose interleukin 2 or high‐dose interleukin 2 alone for inoperable stage III or IV melanoma. Issue 22 (10th October 2018)

8. Phase 2 study of RO4929097, a gamma‐secretase inhibitor, in metastatic melanoma: SWOG 0933. Issue 3 (23rd September 2014)

9. Phase 2 study of RO4929097, a gamma‐secretase inhibitor, in metastatic melanoma: SWOG 0933. Issue 3 (23rd September 2014)